Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease

Clinical trial NCT06206824 · COMPLETED

Trial details

NCT number: NCT06206824
Sponsor: Perha Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Down Syndrome Alzheimer's Disease

Start date: 2024-01-18
Primary completion: 2026-06-25
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.